-
One of the concepts Joe Denney, CHAM, has become familiar with in his position as director of revenue management at The Ohio State University Health System (OSUHS) in Columbus is something called pricing sensitivity, he says.
-
When Donna Madlener agreed to lead the Revenue Enhancement Committee for the James Cancer Hospital, which is part of The Ohio State University Health System (OSUHS) in Columbus, she signed on for a unique experience that went to the heart of such issues as financial responsibility and internal customer service.
-
Whether your hospital has embraced the methodology associated with the term revenue cycle management, chances are youve heard the words bandied about. Certainly the crucial importance of accurate and efficient front-end operations to a health care providers bottom line is emphasized whenever there is a gathering of health care industry leaders.
-
The FDA has mandated a Black Box warning for all estrogen and estrogen/progestin products for use by postmenopausal women. The new warnings are based on analysis of data from the Womens Health Initiative (WHI) study that was published July 2002.
-
Synopsis: DDDR pacing using a right ventricular lead in patients without an indication for antibradycardia pacing is detrimental.
-
The FDA has mandated a Black Box warning for all estrogen and estrogen/progestin products for use by postmenopausal women. The new warnings are based on analysis of data from the Womens Health Initiative (WHI) study that was published July 2002.
-
-
Type 2 nasopharyngeal carcinoma occurs most commonly in the Far East. However, patients with this tumor are being increasingly treated in North America with the increase in the number of Asian communities, particularly in urban areas. In this trial, patients with recurrent, locally advanced, or metastatic nasopharyngeal cancer who presented to a single institution for a 22-month period were treated with either gemcitabine alone or in combination with cisplatin.
-
In a retrospective review of treatment of patients with aggressive lymphoma who had relapsed after stem cell transplantation, single-agent rituximab was shown to induce complete or partial responses in close to 50% of patients. This compares favorably to salvage chemotherapy as reported in prior series.
-
Salvage therapy options for locally recurrent prostate cancer following radiotherapy failure include radical prostatectomy, brachytherapy, and cryotherapy. This study describes the results of the first effort at implementing percutaneous transperineal interstitial photodynamic therapy (PDT) and concludes that local control may be achievable with PDT if better light dosimetry is developed.